(Q38042783)

27 August 2017

Testosterone replacement therapy in the setting of prostate cancer treated with radiation (English)

1 reference

27 August 2017

0 references

1 reference

1 reference

1 reference

A W Pastuszak

1

1 reference

27 August 2017

A M Pearlman

2

1 reference

27 August 2017

G Godoy

3

1 reference

27 August 2017

B J Miles

4

1 reference

27 August 2017

L I Lipshultz

5

1 reference

27 August 2017

M Khera

6

1 reference

27 August 2017

13 September 2012

1 reference

International Journal of Impotence Research

27 August 2017

1 reference

27 August 2017

25

1 reference

27 August 2017

1

1 reference

27 August 2017

24-28

1 reference

https://scigraph.springernature.com/pub.10.1038/ijir.2012.29

27 August 2017

0 references

cites work

Prevalence of symptomatic androgen deficiency in men.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

The dark side of testosterone deficiency: III. Cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

Testosterone replacement therapy after primary treatment for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

Testosterone replacement therapy following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

Testosterone administration to men with testosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

Effect of testosterone administration to men with prostate cancer is unpredictable: a word of caution and suggestions for a registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

Intermittent androgen replacement for intense hypogonadism symptoms in castrated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

Testosterone replacement in prostate cancer survivors with hypogonadal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

Is testosterone a friend or a foe of the prostate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

Hypogonadism following prostate-bed radiation therapy for prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

A multi-institutional observational study of testosterone levels after testosterone pellet (Testopel(®)) insertion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

A phase IV prospective evaluation of the safety and efficacy of extended release testosterone pellets for the treatment of male hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

Identifying differences between biochemical failure and cure: incidence rates and predictors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

7 January 2021

Testosterone therapy in men with untreated prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

7 January 2021

Serum testosterone levels after external beam radiation for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

7 January 2021

The effects of external beam radiotherapy on endocrine function in patients with carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

7 January 2021

Serum testosterone kinetics after brachytherapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

7 January 2021

Effects of external radiation therapy for cancer of the prostate on the serum concentrations of testosterone, follicle-stimulating hormone, luteinizing hormone and prolactin

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

7 January 2021

Influence of radical prostatectomy on serum hormone levels.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

7 January 2021

Total and SHBG-bound testosterone and 5 alpha-dihydrotestosterone serum concentrations in normal elderly men and patients with benign prostatic hypertrophy before and after removal of the adenoma

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

7 January 2021

Suppressive Effects of Surgical Stress on Circulating Androgens During and After Prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

7 January 2021

Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

7 January 2021

Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

7 January 2021

Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.29

7 January 2021

Identifiers

DOI

10.1038/IJIR.2012.29

1 reference

Dimensions Publication ID

27 August 2017

0 references

1 reference